Epidoxorubicin and paclitaxel as primary chemotherapy for T > 3 cm and T4 breast cancer patients.

UNLABELLED The Anthracyclines/Taxanes combination is often used in adjuvant and advanced breast cancer. PURPOSE To evaluate the toxicity and pathological response of sequential epidoxorubicin/paclitaxel combination as primary chemotherapy for T > 3 cm and T4 breast cancer patients. PATIENTS AND METHODS Forty-eight patients with T2 > 3 cm, T3 and T4… (More)